| Market Cap | 0.94M | P/E | - | EPS this Y | - | Ern Qtrly Grth | 48.80% |
| Income | 1.55k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -9.00% |
| Sales | 792.63k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -19.00% |
| Dividend | N/A | Price/Book | 2.42 | EPS next 5Y | - | 52W High Chg | -60.00% |
| Recommedations | - | Quick Ratio | 16.07 | Shares Outstanding | - | 52W Low Chg | 45.00% |
| Insider Own | - | ROA | -1.04% | Shares Float | - | Beta | -0.74 |
| Inst Own | - | ROE | 0.11% | Shares Shorted/Prior | -/- | Price | 0.07 |
| Gross Margin | 80.24% | Profit Margin | 0.20% | Avg. Volume | 22,007 | Target Price | - |
| Oper. Margin | 6.04% | Earnings Date | - | Volume | 53,100 | Change | 11.53% |
InVitro International develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste transportation industries. InVitro International was incorporated in 1985 and is headquartered in Placentia, California.